Biblio Discovery — Demo Discovery Service

4 hasil untuk "Martin Ho"

Menampilkan 1–4 · 0,22 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Impact of supply chain disruptions and drug shortages on drug utilization: A scoping review protocol

    Araniy Santhireswaran; Martin Ho; Kaitlin Fuller dkk.

    PLOS ONE, Vol. 19 No. 11 · 2024 · Inggris · PLOS Scopus

    Objective: This proposed scoping review aims to examine studies assessing the impact of drug shortages on population-level drug utilization trends. The objectives of this review are to a) assess which drugs have been studied and describe associated drug characteristics, b) determine jurisdictions…

  2. Artikel Jurnal Teks lengkap

    Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine

    Sandhya Vasan; Sarah J. Schlesinger; Yaoxing Huang dkk.

    PLoS ONE, Vol. 5 No. 1 · 2010 · Inggris · PLOS Scopus

    Background: We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate HIV-1 vaccine expressing Clade C/B' env, gag, pol, nef, and tat genes. Sequences were derived from a prevalent circulating recombinant form in Yunnan, China, an area of high HIV-1 incidence. The objective was…

  3. Artikel Jurnal Teks lengkap

    Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine

    Sandhya Vasan; Sarah J. Schlesinger; Zhiwei Chen dkk.

    PLoS ONE, Vol. 5 No. 1 · 2010 · Inggris · PLOS Scopus

    Background: We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara viral vector. Sequences were derived from a prevalent circulating HIV-1 recombinant form in Yunnan, China, an area of…

  4. Artikel Jurnal Teks lengkap

    Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

    Walter Jaoko; Etienne Karita; Kayitesi Kayitenkore dkk.

    PLoS ONE, Vol. 5 No. 9 · 2010 · Inggris · PLOS Scopus

    Background: We conducted a double-blind, randomized, placebo-controlled Phase I study of a recombinant replication-defective adenovirus type 5 (rAd5) vector expressing HIV-1 Gag and Pol from subtype B and Env from subtypes A, B and C, given alone or as boost following a DNA plasmid vaccine…